Glucoraphanin Potassium Glucoraphanin is a glucosinolate originally found in cruciferous vegetables of the Brassicaceae family, such as the daikon radish. Glucoraphanin exhibits anti-inflammatory and neuroprotective activities. In an animal model…
Glucaric Acid Calcium Tetrahydrate Glucaric acid is the oxidized, non-cyclic form of a hexose sugar such as glucose. Glucaric acid derivatives exhibit anticancer chemotherapeutic and chemopreventive activities. References PubMed ID：:http://www.ncbi.nlm.nih.gov/pubmed/18928279…
Glucagon, human Glucagon is an endogenous pancreatic peptide hormone that binds glucagon receptors to increase glucose levels and counteract the effects of insulin. Glucagon is clinically used to treat severe…
Glucagon-like Peptide II, rat Glucagon-like peptide 2 (GLP-2) is an endogenous peptide hormone primarily synthesized in the intestine and pancreas. GLP-2 binds and activates the GLP-2 receptor, exhibiting vasodilatory, antihypertensive,…
Glucagon-like Peptide II, human Glucagon-like peptide 2 (GLP-2) is an endogenous peptide hormone primarily synthesized in the intestine and pancreas. GLP-2 binds and activates the GLP-2 receptor, exhibiting vasodilatory, antihypertensive,…
Glucagon-like Peptide I Amide (7-36), human Glucagon-like peptide 1 (GLP-1) is an endogenous peptide hormone that binds GLP-1 receptors, increasing cAMP and insulin secretion. GLP-1 primarily exhibits anorexigenic, anti-diabetic, and…
Glucagon-like Peptide I (7-37) Glucagon-like peptide 1 (GLP-1) is an endogenous peptide hormone that binds GLP-1 receptors, increasing cAMP and insulin secretion. GLP-1 primarily exhibits anorexigenic, anti-diabetic, and gastrointestinal modulatory…
Glucagon (19-29), human Glucagon (19-29) is also known as miniglucagon, an endogenous short peptide co-released with glucagon. Miniglucagon inhibits insulin secretion from pancreatic β-cells in a Ca2+-dependent manner. References PubMed…
GLPG-0634 GLPG-0634 is a triazolopyridine that inhibits JAK1; it exhibits anti-inflammatory and immunomodulatory activities. GLPG-0634 prevents release of inflammatory cytokines and is currently under investigation as a potential treatment for…
Glipizide Glipizide is a second generation sulfonylurea that exhibits anti-diabetic activity. Glipizide inhibits ATP-dependent K+ channels in β cells, forcing cells to remain depolarized, increasing Ca2+ influx and insulin secretion.…